Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03198676
Recruitment Status : Completed
First Posted : June 26, 2017
Last Update Posted : July 2, 2017
Sponsor:
Information provided by (Responsible Party):
Prep Biopharm Limited

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : May 24, 2017
Actual Study Completion Date : May 24, 2017
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 September 19, 2018
February 8, 2019